Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older.
- People who have given signed consent to participate (whenever this is possible).
- People who have been diagnosed with relapsed or refractory multiple myeloma (a type of blood cancer that has come back or stopped responding to treatment) and have already received more than one round of treatment, including at least one treatment plan that included a drug called Isatuximab.
- People for whom genetic test results from a specific test called FISH — including a result for a region called 1q21 — are available from either the time of first diagnosis or at the time the cancer returned (confirm with trial site).
Who may not be able to join:
- There are no listed exclusion criteria for this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 051 636 3 831
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Hematologic response rate, according to the International Myeloma Working Group (IMWG) criteria8 in RRMM with 1q21+ treated with Isa-PD and Isa-KD
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.